Two women to become mums of UK's first 'three parent babies' after radical new treatment approved
Get daily updates directly to your inbox + Subscribe Thank you for subscribing! Could not subscribe, try again later Invalid Email
Two women have been selected to be the first in the UK to have 'three parent babies' after a radical new fertility treatment was approved.
In March last year Newcastle Fertility Centre was given the first licence to create a baby with three genetic parents.
The advanced IVF procedure was developed to prevent children dying from genetic diseases and now individual applications to carry out the mitochondrial replacement therapy (MRT) for two unnamed women have been approved.
The two women carry mutations in a gene that causes a rare condition known as myoclonic epilepsy, or Merrf syndrome, according to minutes from the Human Fertilisation and Embryology Authority’s (HFEA) approval committee.
Merrf syndrome is a neurodegenerative disorder that worsens over time and often results in an early death.
(Image: Getty)
It is usually diagnosed in childhood when people develop sudden spasms which progress to a loss of muscle control, weakness, deafness and dementia.
The HFEA committee reviewed the women’s medical and family histories and concluded that any children they conceived may be affected by “serious multi-systemic and progressive disease” which would severely affect their quality of life.
The aim of MRT will be to stop the mother passing on defective genes in the mitochondria, tiny power plants in cells that supply energy, reports the Newcastle Chronicle .
(Image: Getty Images)
But the technique, which involves giving her an IVF baby with DNA from three individuals, is highly controversial.
The baby will have nuclear DNA from its mother and father that define key characteristics such as personality and eye colour. In addition, it will have a tiny amount of mitochondrial DNA provided by a woman donor - the third “parent”.
Approval of the Newcastle clinic’s facilities, equipment and staff was announced by the HFEA in March, but separate appraisals are still needed to assess the suitability of each candidate.
(Image: PA)
These have to take account of medical history and personal biology to ensure that the procedure is safe and likely to meet with success.
A HFEA spokeswoman said: “Our Statutory Approvals Committee has considered applications from the Newcastle Fertility Centre at Life, part of Newcastle upon Tyne Hospitals NHS Foundation Trust, for the use of mitochondrial donation in treatment for two patients, both of which have been approved.”